Publications by authors named "G Grabner"

White adipose tissue (WAT) comprises a plethora of cell types beyond adipocytes forming a regulatory network that ensures systemic energy homeostasis. Intertissue communication is facilitated by metabolites and signaling molecules that are spread by vasculature and nerves. Previous works have indicated that WAT responds to environmental cues by adapting the abundance of these 'communication routes'; however, the high intra-tissue heterogeneity questions the informative value of bulk or single-cell analyses and underscores the necessity of whole-mount imaging.

View Article and Find Full Text PDF

Bis(monoacylglycero)phosphate (BMP) is a major phospholipid constituent of intralumenal membranes in late endosomes/lysosomes, where it regulates the degradation and sorting of lipid cargo. Recent observations suggest that the Batten disease-associated protein CLN5 functions as lysosomal BMP synthase. Here, we show that transacylation reactions catalyzed by cytosolic and secreted enzymes enhance BMP synthesis independently of CLN5.

View Article and Find Full Text PDF

In mammalian cells, glycerolipids are mainly synthesized using acyl-CoA-dependent mechanisms. The acyl-CoA-independent transfer of fatty acids between lipids, designated as transacylation reaction, represents an additional mechanism for lipid remodeling and synthesis pathways. Here, we demonstrate that human and mouse phospholipase A2 group IVD (PLA2G4D) catalyzes transacylase reactions using both phospholipids and acylglycerols as substrates.

View Article and Find Full Text PDF
Article Synopsis
  • This study examined the effects of inhibiting adipose triglyceride lipase (ATGL) on the progression of metabolic dysfunction-associated steatohepatitis (MASH) and related liver fibrosis in mice on a high-fat diet.
  • Mice treated with the ATGL inhibitor Atglistatin showed improvements in liver health, including lower liver enzymes and reduced lipid accumulation, revealing changes in gene expressions linked to liver and bile acid metabolism.
  • The findings suggest that ATGL inhibition disrupts PPARα signaling pathways and alters bile acid synthesis, which may provide a therapeutic target for treating liver diseases associated with metabolic dysfunction.
View Article and Find Full Text PDF